Northwest Biotherapeutics Inc (NWBO):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10051)
◆英語タイトル:Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10051
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:50
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient’s own dendritic cells as the therapeutic agent. The product has two components, namely, dendritic cells (immune cells) and antigens (cancer biomarkers). The company’s product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM) brain cancer and metastatic ovarian cancer; DCVax-Direct, for the treatment of all inoperable solid tumor cancers; and DCVax-Prostate, for the treatment of late stage prostate cancer. NW Bio is headquartered in Bethesda, Maryland, the US.

Northwest Biotherapeutics Inc (NWBO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Northwest Biotherapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Equity Offering 13
Northwest Biotherapeutics to Raise Funds in Private Placement of Shares 13
Northwest Biotherapeutics Raises USD12 Million in Private Placement of Preferred Stock and Warrants 14
Northwest Biotherapeutics to Raise USD1.8 Million in Private Placement of Shares and Warrants 15
Northwest Biotherapeutics Raises Funds through Private Placement 16
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 17
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 19
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 20
Northwest Biotherapeutics to Raise USD3.7 Million in Private Placement of Shares 21
Northwest Biotherapeutics to Raise USD27.6 Million in Private Placement of Shares 22
Northwest Biotherapeutics Raises USD12.6 Million in Private Placement of Shares 23
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 24
Northwest Biotherapeutics Raises USD40 Million in Private Placement of Shares 25
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 26
Northwest Biotherapeutics Raises USD11.5 Million in Private Placement of Shares 27
Northwest Biotherapeutics Completes Private Placement Of Shares For US$15 Million 29
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 30
Northwest Biotherapeutics Completes Private Placement Of Units For US$15 Million 31
Northwest Biotherapeutics Completes Private Placement Of Shares For US$10 Million 33
Northwest Biotherapeutics Completes Public Offering Of Shares For US$14 Million 34
Debt Offering 36
Northwest Biotherapeutics Raises USD17.5 Million in Private Placement of 5% Notes Due 2017 36
Northwest Biotherapeutics Inc – Key Competitors 37
Northwest Biotherapeutics Inc – Key Employees 38
Northwest Biotherapeutics Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Legal and Regulatory 40
Oct 25, 2017: NW Bio Reports Favorable Results and Progress In Resolving Lawsuits 40
Product News 42
09/01/2017: DCVax-L Clinical Program Updates Presented By Dr. Marnix Bosch At Boston Scientific Conference 42
06/05/2018: Personalized vaccine may increase long-term survival in people with deadliest form of brain cancer 43
Clinical Trials 44
May 31, 2018: NW Bio To Discuss Interim Phase 3 Trial Data In Industry Theater Session During ASCO 44
May 29, 2018: NW Bio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax-L for Glioblastoma Brain Cancer 45
Jun 05, 2017: Dr. Marnix Bosch To Present Update on DCVax-L at the ASCO Conference 47
Feb 06, 2017: NW Bio Announces Lifting of Clinical Hold on DCVax-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached 48
Other Significant Developments 49
Oct 17, 2017: NW Bio Leases Out Warehouse On UK Property to Major Commodities Distribution Firm 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Northwest Biotherapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Northwest Biotherapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Northwest Biotherapeutics to Raise Funds in Private Placement of Shares 13
Northwest Biotherapeutics Raises USD12 Million in Private Placement of Preferred Stock and Warrants 14
Northwest Biotherapeutics to Raise USD1.8 Million in Private Placement of Shares and Warrants 15
Northwest Biotherapeutics Raises Funds through Private Placement 16
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 17
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 19
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 20
Northwest Biotherapeutics to Raise USD3.7 Million in Private Placement of Shares 21
Northwest Biotherapeutics to Raise USD27.6 Million in Private Placement of Shares 22
Northwest Biotherapeutics Raises USD12.6 Million in Private Placement of Shares 23
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 24
Northwest Biotherapeutics Raises USD40 Million in Private Placement of Shares 25
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 26
Northwest Biotherapeutics Raises USD11.5 Million in Private Placement of Shares 27
Northwest Biotherapeutics Completes Private Placement Of Shares For US$15 Million 29
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 30
Northwest Biotherapeutics Completes Private Placement Of Units For US$15 Million 31
Northwest Biotherapeutics Completes Private Placement Of Shares For US$10 Million 33
Northwest Biotherapeutics Completes Public Offering Of Shares For US$14 Million 34
Northwest Biotherapeutics Raises USD17.5 Million in Private Placement of 5% Notes Due 2017 36
Northwest Biotherapeutics Inc, Key Competitors 37
Northwest Biotherapeutics Inc, Key Employees 38
Northwest Biotherapeutics Inc, Subsidiaries 39

List of Figures
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Northwest Biotherapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Northwest Biotherapeutics Inc (NWBO):製薬・医療:M&Aディール及び事業提携情報(Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆